Exelixis (EXEL) Amortizatization of Intangibles (2010 - 2019)
Exelixis' (EXEL) quarterly Amortizatization of Intangibles came in at $704000.0 in Q3 2019, down 74.23% year-on-year from $2.7 million in Q3 2018, and up 6.83% quarter-over-quarter from $659000.0 in Q2 2019.
Exelixis (EXEL) Amortizatization of Intangibles (2010 - 2019) Analysis & Trends
Exelixis' Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $704000.0 for Q3 2019.
- On a quarterly basis, Amortizatization of Intangibles fell 74.23% year-over-year to $704000.0 in Q3 2019; TTM through Sep 2019 was -$6.2 million, a 177.9% decrease from a year earlier, with the FY2018 full-year figure at $2.9 million, changed N/A from the prior year.
- Amortizatization of Intangibles improved to $704000.0 in Q3 2019 per EXEL's latest filing, from $659000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $7.7 million in Q1 2015 and bottomed at -$7.7 million in Q1 2019.
- The 4-year median for Amortizatization of Intangibles is $3.8 million (2015), against an average of $2.7 million.
- Across the five-year window, Amortizatization of Intangibles increased 9.83% in 2015 and tumbled 74.23% in 2019, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $4.8 million in 2015, then advanced by 9.19% to $5.3 million in 2016, then sank by 97.69% to $122000.0 in 2018, then surged by 477.05% to $704000.0 in 2019.
- Per Business Quant, the three latest EXEL Amortizatization of Intangibles figures stand at $704000.0 (Q3 2019), $659000.0 (Q2 2019), and -$7.7 million (Q1 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Exelixis | 14.44 Bn | 13.66 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 27, 2019 | 704,000.00 |
| Sep 27, 2019 | 704,000.00 |
| Jun 28, 2019 | 659,000.00 |
| Jun 28, 2019 | 659,000.00 |
| Mar 29, 2019 | -7.73 Mn |
| Mar 29, 2019 | -7.73 Mn |
| Dec 28, 2018 | 122,000.00 |
| Dec 28, 2018 | 122,000.00 |
| Sep 28, 2018 | 2.73 Mn |
| Sep 28, 2018 | 2.73 Mn |
| Mar 31, 2016 | 5.29 Mn |
| Mar 31, 2016 | 5.29 Mn |
| Dec 31, 2015 | 4.84 Mn |
| Dec 31, 2015 | 4.84 Mn |
| Sep 30, 2015 | 5.30 Mn |
| Sep 30, 2015 | 5.30 Mn |
| Jun 30, 2015 | 7.22 Mn |
| Jun 30, 2015 | 7.22 Mn |
| Mar 31, 2015 | 7.68 Mn |
| Mar 31, 2015 | 7.68 Mn |